
Keywords: α2C-R, α2-adrenergic C receptor; ACA, anti-centromeric antibodies; ANA, antinuclear antibodies; ATII, angiotensin II; CCB, calcium channel blockers; CGRP, calcitonin gene-related peptide; CTD, connective tissue disease(s); DUs, digital ulcers; ET1, endoth